New hope for patients failed by standard blood disorder treatment
NCT ID NCT06786234
First seen Feb 02, 2026 · Last updated Apr 20, 2026 · Updated 11 times
Summary
This early-stage trial is testing a new oral medication called STP938 for adults with high-risk essential thrombocythemia, a blood disorder causing dangerously high platelet counts. The study focuses on patients who can't tolerate or don't respond to the standard treatment, hydroxycarbamide. Participants will take STP938 daily for up to 12 months while researchers monitor how well it controls platelet levels and what side effects occur.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL THROMBOCYTHAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Brest
RECRUITINGBrest, France
-
CHU Nantes
RECRUITINGNantes, France
-
CHU Nice
RECRUITINGNice, France
-
CHU Nîmes
RECRUITINGNîmes, France
-
Cancer and Haematology Centre, Churchill Hospital
RECRUITINGOxford, OX3 7LE, United Kingdom
-
Gustave Roussy
RECRUITINGVillejuif, France
-
Hôpital Saint-Louis
RECRUITINGParis, France
-
Imperial College London / Hammersmith Hospital
RECRUITINGLondon, United Kingdom
-
Institut Paoli-Calmettes
RECRUITINGMarseille, France
-
Royal Hallamshire Hospital
NOT_YET_RECRUITINGSheffield, South Yorkshire, S10 2JF, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sarah Cannon Research Institute
RECRUITINGLondon, United Kingdom
-
University Hospital of Wales
RECRUITINGCardiff, United Kingdom
-
University of Southampton Hospital
RECRUITINGSouthampton, United Kingdom
Conditions
Explore the condition pages connected to this study.